subject: Myriad Genetics, Inc. (mygn) Swot Profile---aarkstore Enterprise Market Research Aggregation [print this page] Summary Summary
Myriad Genetics, Inc. (MYGN) SWOT Profile is a comprehensive business, functional and strategic analysis of Myriad Genetics, Inc.. The profile delves into the operations of the company to present an in-depth analysis of the various aspects related to its business. It analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, executive biographies and key competitors. The hallmark of the profile is the detailed strategic analysis of the company. This highlights and presents an unbiased view of its key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by understanding your partners, customers and competitors better.
Myriad Genetics, Inc. (Myriad) is a research focused biotechnology company engaged in the development and commercialization of small molecular diagnostic products. The company offers different medicine products to improve patients health such as predictive medicine, prognostic medicine and personalized medicine products in the areas of oncology and CNS related disorders. In January 2009, the company acquired all rights of bevirimat from Panacos Pharmaceuticals, Inc.
Key Recent Developments
Apr 19, 2010: Myriad Study Shows PTEN Gene Is Useful In Predicting Prostate Cancer Recurrence
Mar 02, 2010: Myriad Genetics Unveils Prolaris To Predict Prostate Cancer Recurrence
Feb 25, 2010: Patients Of Community Oncology Practices At Risk For Hereditary Breast/Ovarian Cancer: Myriad Genetics
Scope
- Examines key information about company for business intelligence.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented objectively. Business, strategic and operational aspects are taken into account.
- Opportunities available to the company are sized up and its growth potential assessed. Competitive and/or technological threats are highlighted.
- The profile contains valuable and critical company information business structure and operations, the company history, major products and services, prospects, key competitors, key employees, executive biographies, important locations and subsidiaries.
- The profile provides detailed financial ratios for the past five years as well as interim ratios for the last five interim periods for major public companies.
- Financial ratios presented for major public companies include revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Note: Some of the elements mentioned above will be included in the profile based on the availability of information.
